GYREHealthcareSmall-Cap
GYRE THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for GYRE THERAPEUTICS, INC. (GYRE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are GYRE insiders buying or selling?
GYRE THERAPEUTICS, INC. insiders reported 20 open-market buys ($123.1K) and 56 sells ($8.3M) across 76 Form 4 filings — a net selling position of $8.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 22, 2026)
Total Form 4 filings
76
SEC EDGAR
Insider filers
13
Insider buys (20)
$123.1K
Insider sells (56)
$8.3M
Insider sentiment
Net sellingNet insider flow of $8.2M in net selling.
Recent GYRE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 11.0K | $6.25 | $68.7K |
| Jun 15, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 2.8K | $6.17 | $17.3K |
| Jun 11, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 20.9K | $6.16 | $128.9K |
| Jun 8, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 35.0K | $6.25 | $218.6K |
| May 27, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 7.5K | $6.09 | $45.7K |
| May 22, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 22.2K | $6.15 | $136.7K |
| May 20, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 9.3K | $6.38 | $59.4K |
| May 18, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 28.7K | $6.79 | $194.8K |
| May 8, 2026 | Luo Ying | Chief Executive Officer | Sale | 10.3K | $8.04 | $82.9K |
| May 29, 2025 | Ma Songjiang | President | Sale | 2.6K | $10.23 | $26.2K |
| May 27, 2025 | Ma Songjiang | President | Sale | 2.2K | $10.91 | $23.8K |
| May 22, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.04 | $44.2K |
| May 20, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.21 | $44.8K |
| May 16, 2025 | Ma Songjiang | President | Sale | 2.0K | $10.69 | $21.6K |
| May 14, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.97 | $43.9K |
| Mar 25, 2025 | Ma Songjiang | President | Sale | 174 | $10.00 | $1.7K |
| Mar 21, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.11 | $40.4K |
| Mar 19, 2025 | Ma Songjiang | President | Sale | 2.2K | $11.89 | $26.7K |
| Mar 17, 2025 | Ma Songjiang | President | Sale | 4.0K | $12.06 | $48.2K |
| Mar 13, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.57 | $46.3K |
| Mar 11, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.19 | $40.8K |
| Mar 7, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.89 | $43.6K |
| Mar 5, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.05 | $44.2K |
| Mar 3, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.37 | $45.5K |
| Feb 27, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.50 | $46.0K |
Showing the 25 most recent of 76 Form 4 filings for GYRE THERAPEUTICS, INC..
Most active GYRE insiders
- Ma Songjiang39 filings
- Nassim Usman10 filings
- Weiguo Ye8 filings
- Howard Levy5 filings
- Grant E. Blouse3 filings
Ask anything about GYRE insider activity
Use Trabud's AI agent to query GYRE THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me GYRE CEO purchases this year" or compare it against any other ticker.
Open the AI agentGYRE insider trading FAQ
Are GYRE THERAPEUTICS, INC. insiders buying or selling?
Across 76 SEC Form 4 filings, GYRE THERAPEUTICS, INC. (GYRE) insiders reported 20 open-market purchases totaling $123.1K and 56 sales totaling $8.3M. That is a net selling position of $8.2M.
How many insiders trade GYRE stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GYRE THERAPEUTICS, INC.. The most recent filing was accepted on Jun 22, 2026.
Where does Trabud get GYRE insider trading data?
All GYRE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.